Author - Abby Hardy

Markets

Profound Medical closes $10-million bought deal

Profound Medical (TSXV:PRN; OTCQX:PRFMF) closed a bought deal financing for total proceeds of $10-million. The company sold 10 million units at a price of $1 each, with each unit consisting of one common share of...

September 20, 2017

Executive Moves

Ortho RTi CSO appointed bioengineering chair at George Mason

Ortho Regenerative Technologies said its chief scientific officer, Michael Buschmann, has been appointed as bioengineering chair, professor and eminent scholar (an award from Virginia’s Center for Innovative...

September 7, 2017

Developments

Titan Pharma Parkinson’s drug implant in Fortune

An article on Fortune magazine’s web site discusses Titan Pharmaceuticals (NASDAQ:TTNP) and its newest implant with a commonly used Parkinson’s disease drug called ropinirole. Last week, the FDA gave Titan the green...

August 28, 2017

Author - Abby Hardy

Profound Medical closes $10-million bought deal

Ortho RTi CSO appointed bioengineering chair at George Mason

Titan Pharma Parkinson’s drug implant in Fortune

Subscribe